Ursodeoxycholic Acid at 18–22 mg/kg/d Showed a Promising Capacity for Treating Refractory Primary Biliary Cholangitis

AIM: To compare the response between the current recommended dosage 13–15 mg/kg/d and 20 mg/kg/d dose of ursodeoxycholic acid (UDCA) in primary biliary cholangitis (PBC) patients who do not respond completely to a standard dose of UDCA. METHODS: We included 73 patients with poor response and randomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Xinyu, Yang, Xiaoli, Shen, Mengyi, Huang, Chen, Liu, Yifeng, Fan, Xiaoli, Yang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843178/
https://www.ncbi.nlm.nih.gov/pubmed/33542908
http://dx.doi.org/10.1155/2021/6691425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843178/
https://www.ncbi.nlm.nih.gov/pubmed/33542908
http://dx.doi.org/10.1155/2021/6691425

Ejemplares similares